Listed Companies
Search for Company
Latest Results
Financial Reports
ESG Reports
Announcements / Notices
Returns on Share Capital
Circulars
Prospectuses
Press Releases
Presentations / Webcasts
Stock Quotes
Corporate Governance
Upcoming Events
Sign Up
Seminars / Conferences
IR Services Directory
Investment Community
Resource Center
HK Statutory Notices
Pharmaxis Ltd
Press Releases
Please download the latest "
Acrobat Reader
" to view the PDF.
2013-December-10
Scottish Medicines Consortium Accepts Bronchitol for CF Use (in PDF)
2013-November-27
Chairman's Address to Shareholders (in PDF)
2013-October-30
Pharmaxis Elects to Receive Full NovaQuest Investment (in PDF)
2013-October-15
Pharmaxis Quarterly Investor Conference Call (in PDF)
2013-September-19
Pharmaxis Announces Two Board Retirements (in PDF)
2013-August-29
Pharmaxis Announces Delay to French Pricing for Bronchitol (in PDF)
2013-July-18
Pharmaxis Announces Improved PBS Listing of Bronchitol (in PDF)
2013-July-16
Pharmaxis Quarterly Investor Conference Call (in PDF)
2013-July-5
Pharmaxis Awarded Two ARC Linkage Grants (in PDF)
2013-June-20
European CF Clinical Trial in Paediatric Patients Begins (in PDF)
2013-June-18
Pharmaxis Presents New Analyses of Pooled CF Data at EU Meet (in PDF)
2013-June-7
CEO Remuneration and Employee Performance Rights (in PDF)
2013-June-3
Aridol FDA Import Restrictions (in PDF)
2013-May-28
Outcome of Business Review (in PDF)
2013-May-24
Investor Conference Call - Results of Business Plan (in PDF)
2013-May-22
Pharmaxis Appoints Bronchitol Distributor for Poland (in PDF)
2013-May-21
Pharmaxis Agrees Key Cystic Fibrosis Trial Paramaters with FDA on Bronchitol (in PDF)
2013-May-14
FDA Meeting, Business Review Announcement End of May (in PDF)
2013-April-24
Phase 3 Clinical Trial in Bronchiectasis (B305) (in PDF)
2013-April-23
Pharmaxis Conference Call (in PDF)
2013-April-10
Pharmaxis Announces Bronchitol Distributor for Brazil (in PDF)
2013-April-10
Quarterly Investor Conference Call (in PDF)
2013-March-19
Pharmaxis Receives Complete Response Letter from FDA (in PDF)
2013-March-12
Pharmaxis Appoints Gary Phillips New Chief Executive Officer (in PDF)
2013-March-8
Bronchiectasis Phase 3 Trial Milestone (in PDF)
2013-January-31
Pharmaxis Announces US$40 Million Financing Agreement (in PDF)
2013-January-31
Pharmaxis Receives Negative Recommendation from PADAC (in PDF)
2013-January-22
Investor Conference Call and Quarterly Report (in PDF)
2017
2017 Press Releases
2016
2016 Press Releases
2015
2015 Press Releases
2014
2014 Press Releases
2012
2012 Press Releases
2011
2011 Press Releases
2010
2010 Press Releases
2009
2009 Press Releases
2008
2008 Press Releases
2007
2007 Press Releases
2006
2006 Press Releases
2005
2005 Press Releases
2004
2004 Press Releases
Company's Index
irasia.com